Conversely, in our tumor with MSI, the mutator phenotype could have been triggered by ARID1A driver alterations impairing MSH2 recruitment for DNA repair, without initial detection/no presence of MMR gene mutations, and with immunotherapy response due to MMR deficiency. The gene discussed is MSH2; the disease is neoplasm.